Abstract
Background
The aim of this study was to assess whether patients diagnosed with oesophageal or gastric cancer at a local district general hospital (the “spoke”) have a similar temporal pathway through the decision-making and treatment process compared to those patients presenting at the centralised, tertiary hospital (the “hub”).
Methods
Between April 2010 and April 2011, patients with a new diagnosis of oesophagogastric cancer from both hub and spoke hospitals were analysed. Data regarding diagnosis, time from diagnosis to multidisciplinary meeting (MDM) discussion, and time from MDM decision to first treatment were all recorded. Statistical analysis was performed using parametric two-tailed t test to assess significance.
Results
There was a statistically significant increase in the time from diagnosis to MDM discussion at the spoke hospital compared to the hub (13.3 days vs. 25.67 days; p = 0.001). However, time to first treatment (surgery, palliative therapy, neoadjuvant therapy, or best supportive care) was significantly increased in the hub hospital compared to the spoke (43.4 days vs. 25.5 days; p = 0.023).
Conclusions
Notwithstanding its limitations, this study is the first of its kind to show that there is a disparity in the management pathways of patients who first present to a regional hospital rather than the tertiary centre. Patients at the spoke hospital have a longer lead time into the MDM but nonoperative treatment appears to be delivered more quickly locally.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Polednak AP (2003) Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer 105(1):98–100
Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349:2117–2127
Gill AJ, Martin IG (2002) Survival from upper gastrointestinal cancer in New Zealand: the effect of distance from a major hospital, socio-economic status, ethnicity, age and gender. ANZ J Surg 72:643–646
Department of Health (2001) Improving outcomes in upper gastrointestinal cancers. Department of Health, London. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4010025
Siriwardena AK (2007) Centralisation of upper gastrointestinal cancer surgery. Ann R Coll Surg Engl 89:335–336
Siewert JR, Stein HJ (1986) Carcinoma of the gastroesophageal junction: classification, pathology and extent of resection. Dis Esophagus 9:173–182
Macleod U, Mitchell ED, Burgess C et al (2009) Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer 101(Suppl 2):S92–S101
Forshaw MJ, Gossage JA, Stephens J et al (2006) Centralisation of oesophagogastric cancer services—can specialist units deliver? Ann R Coll Surg Engl 88:566–570
Acknowledgments
The authors thank Serena Hodges, MDM Coordinator, and Joanne Price, Upper GI Cancer Specialist Nurse, for access to patient databases.
Disclosures
Monkhouse S. J, Torres-Grau J, Bawden D. R, Ross C, and Krysztopik R. J. have no conflicts of interest or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Monkhouse, S.J., Torres-Grau, J., Bawden, D.R. et al. Centralisation of upper-GI cancer services: is the hub quicker than the spoke?. Surg Endosc 27, 565–568 (2013). https://doi.org/10.1007/s00464-012-2486-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-012-2486-y